Florida Firm's OTC Tattoo Pain Relief Get FDA's Unapproved Stamp

22 Dec 2017
News

Malcolm Spicer @TheTanSheet malcolm.spicer@informa.com

Executive Summary

FDA warning based on an inspection of AIG Technologies' facility from September through November 2015. The firm responded without "supporting documentation" to FDA and the agency has been unable to verify the adequacy of its corrective actions.

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

United States

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

Drug Approval Standards FDA Manufacturing

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS122192

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS122192

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Florida Firm's OTC Tattoo Pain Relief Get FDA's Unapproved Stamp

News

Executive Summary

Related Content

Kitchen-Made Healing Treatments Among Health And Wellness Recalls

Making OTC Topical Drugs In Kitchen Stirs Up Problems For Oregon Firm

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert